Donna Shoupe — Endo Lab

review 2024

Estrogen deficiency in the menopause and the role of hormone therapy: integrating the findings of basic science research with clinical trials

Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000002407

Menopause, defined by the cessation of menstrual cycles after 12 months of amenorrhea not due to other causes, is associated with significant hormonal changes, primarily a decrease in estrogen, androgen, and progesterone levels. This review…

2023

Management of Pelvic Pain

·doi:10.1007/978-3-031-14881-1_86

2022

Management of Pelvic Pain

·doi:10.1007/978-3-319-17002-2_86-2

2022

SUBSTANTIAL VARIABILITY IN OVARIAN CONSERVATION AT HYSTERECTOMY FOR ENDOMETRIAL HYPERPLASIA

·doi:10.1016/j.fertnstert.2022.08.670

review 2021

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control

Contraception and reproductive medicine ·doi:10.1186/s40834-020-00142-5

Since the introduction of the first modern contraceptive methods, the interlink between bleeding control and contraceptive development has been a dominant and critical factor. This interplay has led to the development of safer and better co…

observational 2019

Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer

Gynecologic Oncology ·doi:10.1016/j.ygyno.2019.04.653

OBJECTIVE: To profile patient characteristics associated with and outcomes of ovarian conservation at the time of hysterectomy in young women with minimal-risk endometrial cancer. METHODS: A population-based retrospective analysis of the N…

2019

Patterns of utilization and outcomes of ovarian conservation for young women with minimum-risk endometrial cancer

·doi:10.1016/j.ygyno.2019.04.246

2017

Management of Pelvic Pain

·doi:10.1007/978-3-319-17798-4_86

other 2016

LARC methods: entering a new age of contraception and reproductive health

Contraception and reproductive medicine ·doi:10.1186/s40834-016-0011-8

review 2006

Long-Acting Progestin Injectables

·doi:10.1007/978-1-59745-150-5_7

Depo-Provera® (depot medroxyprogesterone acetate [DMPA]) is an extremely effective contraceptive agent. Since its introduction into the market in the 1960s, DMPA has been used for a variety of gynecological conditions including endometriosi…

2005

Ovarian Conservation at the Time of Hysterectomy for Benign Disease

·doi:10.1097/01.aog.0000186258.37099.a2

Parker, William H. MD; Broder, Michael S. MD, MPH; Berek, Jonathan S. MD, MMSc; Liu, Zhimei PhD; Shoupe, Donna MD; Farquhar, Jonathan S. MD Author Information

2005

Ovarian Conservation at the Time of Hysterectomy for Benign Disease

·doi:10.1097/01.aog.0000190481.84868.7d

Parker, William H. MD; Broder, Michael S. MD, MPH; Liu, Zhimei PhD; Shoupe, Donna MD; Farquhar, Cindy MD; Berek, Jonathan S. MD, MMSc Author Information

2001

Hysteroscopic view 6 to 30 months after cryoablation in 20 patients

·doi:10.1016/s1074-3804(01)80086-4

2001

Month data from multicenter study of her option uterine cryoablation versus rollerball electroablation in women with menorrhagia

·doi:10.1016/s1074-3804(01)80088-8

2001

Uterine cryoablation therapy in women with menorrhagia

·doi:10.1016/s1074-3804(01)80089-x

review 2000

Hysterectomy or an alternative?

Hospital practice (1995) ·doi:10.3810/hp.2000.09.213

Even though hysterectomy remains an appealing solution for a number of nonmalignant gynecologic conditions, patients are often scheduled for surgery without proper evaluation or consideration of an alternative. For symptoms associated with …